Success of malaria chemoprophylaxis for outbound civil and military travellers in prevention of reintroduction of malaria in Sri Lanka

Sumadhya D Fernando, Dewanee Ranaweera, Methnie S Weerasena, Rahuman Booso, Thamara Wickramasekara, Chirath P Madurapperuma, Manjula Danansuriya, Chaturaka Rodrigo, Hemantha Herath, Sumadhya D Fernando, Dewanee Ranaweera, Methnie S Weerasena, Rahuman Booso, Thamara Wickramasekara, Chirath P Madurapperuma, Manjula Danansuriya, Chaturaka Rodrigo, Hemantha Herath

Abstract

Background: Sri Lanka was certified as malaria-free in September 2016. However, the continuous presence of the malaria vector poses serious risks of reintroduction of the disease. Chemoprophylaxis and advice on malaria preventive behaviour for international travellers is a key strategy adopted to reduce the risk of imported malaria.

Methods: We conducted an efficiency study of malaria chemoprophylaxis for civilian and military travellers who requested travel advice from the Anti Malaria Campaign (AMC) prior to departure. The AMC is the only agency that can issue malaria chemoprophylaxis to travellers and hence this sample is representative of all such individuals seeking travel advice in Sri Lanka.

Results: A total of 544 (400 civilians and 144 military) travellers were interviewed prior to departure and after return. The majority travelled to African destinations (516/544 [94.8%]) and were prescribed mefloquine (517/544 [95%]). Chemoprophylaxis was well tolerated and discontinuation due to adverse events was minimal. Regular chemoprophylaxis was reported by 505 (92.8%) participants while overseas. The protective efficacy of chemoprophylaxis was 100% among those who complied with the full course.

Conclusions: The compliance with chemoprophylaxis and its protective efficacy were satisfactory in this study. It is an effective tool in preventing imported malaria to post-elimination Sri Lanka.

Keywords: chemoprophylaxis; adverse effects; imported malaria; malaria; mefloquine; reintroduction.

© The Author(s) 2019. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Figures

Figure 1
Figure 1
Leaflets handed out to travellers highlighting the importance of chemoprophylaxis.

References

    1. World Health Organization World malaria report. Geneva:World Health Organization, 2017.
    1. Tatem AJ, Jia P, Ordanovich D, Falkner M, et al.. The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics. Lancet Infect Dis. 2017;17(1):98–107.
    1. MacPherson DW, Gushulak BD, Baine WB, et al.. Population mobility, globalization, and antimicrobial drug resistance. Emerg Infect Dis. 2009;15(11):1727–1732.
    1. Smith AD, Bradley DJ, Smith V, et al.. Imported malaria and high risk groups: observational study using UK surveillance data 1987–2006. BMJ. 2008;337(7661):103–106.
    1. Chen LH, Wilson ME, Schlagenhauf P. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA. 2007;297(20):2251–2263.
    1. Moore DA, Grant AD, Armstrong M, Stumpfle R, Behrens RH. Risk factors for malaria in UK travellers. Trans R Soc Trop Med Hyg. 2004;98(1):55–63.
    1. Sagui E, Resseguier N, Machault V, et al.. Determinants of compliance with anti-vectorial protective measures among non-immune travellers during missions to tropical Africa. Malar J. 2011;10:232.
    1. Toovey S, Jamieson A. Rolling back malaria: how well is Europe doing? Travel Med Infect Dis. 2003;1(3):167–175.
    1. Mendis K, Rietveld A, Warsame M, Bosman A, Greenwood B, Wernsdorfer WH. From malaria control to eradication: the WHO perspective. Trop Med Int Health. 2009;14(7):802–809.
    1. World Health Organization Malaria elimination: a field manual for low and moderate endemic countries. Geneva:World Health Organization, 2007.
    1. Cohen JM, Moonen B, Snow RW, Smith DL. How absolute is zero? An evaluation of historical and current definitions of malaria elimination. Malar J 2010;9:213.
    1. World Health Organization WHO Expert Committee on Malaria: twelfth report. Geneva:World Health Organization, 1966.
    1. Feachem RG, Phillips AA, Hwang J, et al.. Shrinking the malaria map: progress and prospects. Lancet. 2010;376(9752):1566–1578.
    1. Moonen B, Cohen JM, Tatem AJ, et al.. A framework for assessing the feasibility of malaria elimination. Malar J. 2010;9:322.
    1. Premaratne R, Ortega L, Janakan N, Mendis KN. Malaria elimination in Sri Lanka: what it would take to reach the goal. WHO South-East Asia journal of public health 2014;(1):85–89.
    1. Anti Malaria Campaign Annual report Colombo:Ministry of Health, Nutrition and Indigenous Medicine; 2017.
    1. Anti Malaria Campaign Annual report Colombo:Ministry of Health, Nutrition and Indigenous Medicine; 2009.
    1. Anti Malaria Campaign Annual report Colombo:Ministry of Health, Nutrition and Indigenous Medicine; ; 2010.
    1. Anti Malaria Campaign Annual report Colombo:Ministry of Health, Nutrition and Indigenous Medicine; 2011.
    1. Anti Malaria Campaign Annual report Colombo:Ministry of Health, Nutrition and Indigenous Medicine; 2012.
    1. Galappaththy GN, Fernando SD, Abeyasinghe RR. Imported malaria: a possible threat to the elimination of malaria from Sri Lanka? Trop Med Int Health. 2013;18(6):761–768.
    1. Cook IF. Malaria prevention. Lancet. 1986;328(8500):229.
    1. DePetrillo JC, Singer C, Bergagnini IA, Kolakowski P, Edwards B, Smith MA. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers. J Travel Med. 2010;17(4):217–220.
    1. Croft AM, Whitehouse DP, Cook GC, Beer MD. Safety evaluation of the drugs available to prevent malaria. Expert Opin Drug Saf. 2002;1(1):19–27.
    1. Cobelens FG, Leentvaar-Kuijpers A. Compliance with malaria chemoprophylaxis and preventative measures against mosquito bites among Dutch travellers. Trop Med Int Health. 1997;2(7):705–713.
    1. Fernando SD, Booso R, Dharmawardena P, et al.. The need for preventive and curative services for malaria when the military is deployed in endemic overseas territories: a case study and lessons learned. Mil Med Res. 2017;4:19.
    1. Lwanga SK, Lemeshow S. Sample size determination in health studies: a practical manual. Geneva:World Health Organization, 1991.
    1. Kitchener SJ, Nasveld PE, Gregory RM, Edstein MD. Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor. Med J Aust. 2005;182(4):168–171.
    1. Adshead S. The adverse effects of mefloquine in deployed military personnel. J R Nav Med Serv. 2014;100(3):232–237.
    1. Meier CR, Wilcock K, Jick SS. The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Saf. 2004;27(3):203–213.
    1. Gogtay NJ, Ferner RE. Mefloquine for malarial prophylaxis in military personnel. BMJ. 2015;351: h5797.
    1. Wickremasinghe AR, Wickremasinghe R, Herath HD, Fernando SD. Should chemoprophylaxis be a main strategy for preventing re-introduction of malaria in highly receptive areas? Sri Lanka a case in point. Malar J. 2017;16:102.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel